Improving the outcome of treating striae gravidarum by combined therapies using topical β‐glucan and 1565‐nm non‐ablative fractional laser: A prospective randomized vehicle‐controlled parallel group study

Abstract Striae gravidarum (SG) is a kind of dermal scar associated with psychosocial and therapeutic challenge. Topical reagents and non‐invasive laser are more preferred than invasive procedures for less pain and shorter downtime. However, there are few studies on comparing and combining these two modalities. The aim of the present study was to evaluate the efficacy and tolerance of a topical regimen containing β‐glucan, 1565‐nm non‐ablative fractional laser (NAFL; ResurFX), and combination of them for SG. A total of 128 unilateral abdomens from 64 subjects were randomly divided into four strategies and were followed up for 12 weeks: topical vehicle (Veh); topical β‐glucan (B); 1565‐nm NAFL combined topical vehicle (NAFL); 1565‐nm NAFL combined topical β‐glucan (B + NAFL). NAFL was applied three times with a 4‐week interval. Topical reagent was applied b.i.d. for 12 weeks. Global Aesthetic Improvement Scale (GAIS) scores were assessed by blinded physician according to standard photograph, and by subjects at 12th week. The degree of SG atrophy was assessed by blinded physician before treatment and at the 12th week according to a standard 5‐point scale. Collagen remodeling was evaluated by histological analysis and all adverse effects were recorded. A total of 56 women (112 unilateral abdomens) completed all study. The GAIS scores by blinded physician showed greater improvement in NAFL as compared with β‐glucan, and by subjects showed greater improvement in β‐glucan as compared with vehicle. In terms of striae atrophy scale, the improvement of SG atrophy was more prominent in NAFL compared to β‐glucan, and in β‐glucan + NAFL compared to Veh + NAFL. All treatments were well tolerated. Topical β‐glucan regimen can mildly improve SG. NAFL showed better results than topical β‐glucan regimen. The combined strategy may further improve the SG atrophy compared with single treatment strategy.